Citation Impact
Citing Papers
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
2008 StandoutScienceNobel
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
2003 StandoutScienceNobel
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
2011 StandoutScience
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Diversity of the Human Intestinal Microbial Flora
2005 StandoutScience
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis
2010
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
1989
Ten years' experience with an elemental diet in the management of Crohn's disease.
1990
Lymphoid Hyperplasia, Autoimmunity, and Compromised Intestinal Intraepithelial Lymphocyte Development in Colitis-Free Gnotobiotic IL-2-Deficient Mice
1998
CD4+ Tregs and immune control
2004 StandoutNobel
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine
2003
Inflammation and cancer
2002 StandoutNature
Management of Crohn's disease in adults
2001
n-3 Fatty acids for the treatment of inflammatory bowel diseases
2002
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
1995
The anatomical basis of intestinal immunity
1997
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Early Identification of Refractory Epilepsy
2000 Standout
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Microbial factors in inflammatory bowel disease
2002
Regulatory T Cells
2000 StandoutNobel
The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives
1989
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
2007 StandoutNatureNobel
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Commensal-Associated Molecular Patterns Induce Selective Toll-Like Receptor-Trafficking from Apical Membrane to Cytoplasmic Compartments in Polarized Intestinal Epithelium
2002
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Oral Budesonide for Active Crohn's Disease
1994
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
2004
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
1991
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease
2002
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
1995
Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial
1996
Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury
2010
Host–microbiota interactions in inflammatory bowel disease
2020
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Inflammatory bowel disease is not associated with an increased risk of lymphoma
2001
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
Microbial Influences in Inflammatory Bowel Diseases
2008
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial
1999
Mucosal flora in inflammatory bowel disease
2002
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Inflammatory Bowel Disease
2002 Standout
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria
2005
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis
2005
Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens
2002
Effects of Highly Purified Eicosapentaenoic Acid on Erythrocyte Fatty Acid Composition and Leukocyte and Colonic Mucosa Leukotriene B4 Production in Children With Ulcerative Colitis
2003
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
2006
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis
2002
Intestinal permeability and the prediction of relapse in Crohn's disease
1993
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Oral pentasa in the treatment of active Crohn’s disease: A meta-analysis of double-blind, placebo-controlled trials
2004
Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
2004
Regulatory T cells in the control of immune pathology
2001
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
Control of immune pathology by regulatory T cells
1998
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Points of control in inflammation
2002 StandoutNature
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Regulatory T cells and inflammatory bowel disease
1999
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin‐10 or antibodies to interleukin‐12
1996
Elevated flagellin-specific immunoglobulins in Crohn's disease
2004
Methotrexate for the Treatment of Crohn's Disease
1995
Interactions between dendritic cells and bacteria in the regulation of intestinal immunity
2004
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
2005
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases
2008
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
1993
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
Guidelines for the management of inflammatory bowel disease in adults
2004
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Bacterial flagellin is a dominant antigen in Crohn disease
2004
CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms
2003
The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery
2003 StandoutNobel
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
2010
Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora
2002 StandoutScienceNobel
Induction of colitis by a CD4+T cell clone specific for a bacterial epitope
2003
Comparison of enteral nutrition and drug treatment in active Crohn's disease
1991
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Intestinal Inflammation and the Gut Microflora
1999
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
1996
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
2004 StandoutNobel
Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo
2006
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Polyunsaturated fatty acids and inflammatory bowel disease
2000
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
Colitogenic Th1 Cells Are Present in the Antigen-Experienced T Cell Pool in Normal Mice: Control by CD4+ Regulatory T Cells and IL-10
2003
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Alternatives to sulfasalazine: A meta-analysis of 5-ASA in the treatment of ulcerative colitis
1997
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells
2005
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease
2000
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis
1998
Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis
2002
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Single dose of anti–CTLA-4 enhances CD8 + T-cell memory formation, function, and maintenance
2010 StandoutNobel
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
1996
Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts
1999
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.
1997
Citrobacter rodentiumInfection in Mice Elicits a Mucosal Th1 Cytokine Response and Lesions Similar to Those in Murine Inflammatory Bowel Disease
1999
Bacterial flagellin is a dominant antigen in Crohn disease
2004
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities
1989
Works of Klaus Ewe being referenced
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
1998
Corticosteroids for maintenance of remission in Crohn's disease
2003
Treatment of Ulcerative Colitis with Olsalazine and Sulphasalazine: Efficacy and Side-Effects
1988
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases
2000
N-3 fatty acids only delay early relapse of ulcerative colitis in remission
1996
Low-dose budesonide treatment for prevention of postoperative recurrence of Crohnʼs disease
1999
Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector
1991
Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease
1993
Einfluß der Nahrungsaufnahme auf die Magenentleerung magensaftresistenter Tabletten und Kapseln*
2008
Inflammation Does Not Decrease Intraluminal pH in Chronic Inflammatory Bowel Disease
1999
Effect of Bisacodyl on Intestinal Electrolyte and Water Net Transport and Transit
1987
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
1984
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
1995
78. Operative Radikalität und Rezidivprophylaxe mit Azulfidine bei M. Crohn: Eine prospektive multizentrische Studie - Erste Ergebnisse
1984